Raymond James Financial Services Advisors, Inc. My Md Pharmaceuticals, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024
SELL
$0.22 - $0.58 $2,200 - $5,800
-10,000 Reduced 45.0%
12,223 $3,000
Q3 2023

Oct 24, 2023
SELL
$0.47 - $1.87 $1,786 - $7,106
-3,800 Reduced 14.6%
22,223 $13,000
Q1 2023

Apr 14, 2023
BUY
$1.1 - $2.86 $1,345 - $3,497
1,223 Added 4.93%
26,023 $44,000
Q4 2022

Feb 08, 2023
SELL
$0.92 - $96.0 $0 - $96
-1 Reduced -0.0%
24,800 $28,000
Q3 2022

Oct 25, 2022
BUY
$2.22 - $82.2 $55,058 - $2.04 Million
24,801 New
24,801 $65,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email